HYRIMOZ

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 61314-454
  • Package NDC 61314-454-20
  • Package NDC 61314-454-36
  • Package NDC 61314-454-68
  • Application number BLA761071
  • SPL ID 48b7e44a-945f-487d-b2fd-3da13d6d6fdb
  • SPL set ID 1ac7d061-3380-468c-b077-c05f8dfbc829
  • UNII FYS6T7F842
  • RxCUI 2641644
  • RxCUI 2641650
  • RxCUI 2641653
  • RxCUI 2641654
  • RxCUI 2641655
  • RxCUI 2641658
  • RxCUI 2641660
  • RxCUI 2641661
  • RxCUI 2641662
  • RxCUI 2641663
  • RxCUI 2641664
  • RxCUI 2641665
  • RxCUI 2641666
  • RxCUI 2641667
  • RxCUI 2641668
  • RxCUI 2641669
  • RxCUI 2641670
  • RxCUI 2641671
  • RxCUI 2641672
  • RxCUI 2641673

What the source publishes

Labeler
Sandoz Inc
Active ingredients
adalimumab-adaz
Form
INJECTION, SOLUTION
Routes
SUBCUTANEOUS
Administrative status
present-in-source-snapshot
Marketing status
BLA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:61314-454_48b7e44a-945f-487d-b2fd-3da13d6d6fdb
{
  "name": "HYRIMOZ",
  "splId": "48b7e44a-945f-487d-b2fd-3da13d6d6fdb",
  "labels": [
    {
      "setId": "1ac7d061-3380-468c-b077-c05f8dfbc829",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1ac7d061-3380-468c-b077-c05f8dfbc829",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1ac7d061-3380-468c-b077-c05f8dfbc829"
    }
  ],
  "routes": [
    "SUBCUTANEOUS"
  ],
  "labeler": "Sandoz Inc",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "2 SYRINGE in 1 CARTON (61314-454-20)  / .8 mL in 1 SYRINGE",
      "package_ndc": "61314-454-20",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20230701"
    },
    {
      "sample": false,
      "description": "3 SYRINGE in 1 CARTON (61314-454-36)  / .8 mL in 1 SYRINGE",
      "package_ndc": "61314-454-36",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20230701"
    },
    {
      "sample": false,
      "description": "3 SYRINGE, GLASS in 1 CARTON (61314-454-68)  / .8 mL in 1 SYRINGE, GLASS",
      "package_ndc": "61314-454-68",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20230701"
    }
  ],
  "productId": "61314-454_48b7e44a-945f-487d-b2fd-3da13d6d6fdb",
  "useDomain": "unknown",
  "dosageForm": "INJECTION, SOLUTION",
  "productNdc": "61314-454",
  "deaSchedule": null,
  "genericName": "adalimumab-adaz",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "ADALIMUMAB",
      "strength": "80 mg/.8mL"
    }
  ],
  "applicationNumber": "BLA761071",
  "marketingCategory": "BLA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20230701",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000175610",
      "N0000175451",
      "M0001357"
    ],
    "unii": [
      "FYS6T7F842"
    ],
    "rxcui": [
      "2641644",
      "2641650",
      "2641653",
      "2641654",
      "2641655",
      "2641658",
      "2641660",
      "2641661",
      "2641662",
      "2641663",
      "2641664",
      "2641665",
      "2641666",
      "2641667",
      "2641668",
      "2641669",
      "2641670",
      "2641671",
      "2641672",
      "2641673"
    ],
    "spl_set_id": [
      "1ac7d061-3380-468c-b077-c05f8dfbc829"
    ],
    "pharm_class_cs": [
      "Antibodies, Monoclonal [CS]"
    ],
    "pharm_class_epc": [
      "Tumor Necrosis Factor Blocker [EPC]"
    ],
    "pharm_class_moa": [
      "Tumor Necrosis Factor Receptor Blocking Activity [MoA]"
    ],
    "manufacturer_name": [
      "Sandoz Inc"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:61314-454_48b7e44a-945f-487d-b2fd-3da13d6d6fdb"